Guizhou Xinbang Pharmaceutical Co., Ltd. (SZSE:002390) announces a share repurchase program. Under the program, the company will repurchase up to 30,000,000 shares, representing 1.76% of its share capital, for a total consideration of CNY300 million. The repurchase price will not exceed CNY10 per share. The shares repurchased will be cancelled. The purpose of the program is to reduce the company’s registered capital. The program will be funded from its own funds. The program is subject to shareholder approval. The program will run for a period of 12 months starting from the approval date of this repurchase plan by the company’s shareholders’ meeting.